- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 1.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.8M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 530.62K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$804.28K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$926.13K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.67M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.38M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.91M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.48M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $309.39K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $418.59K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $309.39K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $418.59K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.98M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.8M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.98M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.8M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.43 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.92 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.43 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.92 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $663.46K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $614.91K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $141.6K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $423.58K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$765.99K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.02M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$805.05K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.04M |